Former President Joe Biden Limits Book Tour Due to Cancer Treatment

Former U.S. President Joe Biden announced that he will significantly scale back his upcoming promotional tour for his memoir, "Promise Me, America," noting that his ongoing cancer treatments sometimes slow him down. The 83-year-old former president shared the update in a statement posted on social media, explaining that while some days are better than others, the rigorous schedule of public appearances has become too demanding.

Biden announced his diagnosis of an aggressive form of prostate cancer in May 2025, several months after completing his term in the White House. Since then, he has undergone radiation therapy and hormone treatments. While his doctors remain encouraged by his response to the medical care, his family has previously shared that the illness has advanced, noting in August that the cancer had metastasized to his bones and caused considerable pain.

Despite scaling back his promotional events, Biden expressed hope that his memoir, scheduled for release on November 17, will resonate with readers. The book details his four years in the White House, the policy decisions he made, and the circumstances surrounding his choice to step aside from the 2024 presidential race. He thanked the public for their continued prayers and well wishes as he maintains his focus on treatment.

Beyond political news, recent developments in healthcare highlight both the ongoing battle against cancer and innovative approaches to treatment. In the pharmaceutical sector, commercial companies are increasingly looking to space to improve drug manufacturing. Utilizing microgravidade environments in low Earth orbit, firms such as Varda Space Industries and BioOrbit are experimenting with growing pharmaceutical crystals in small, automated spacecraft.

Researchers note that on Earth, gravity interferes with the uniform formation of molecular structures in liquids. In the reduced gravity of space, particles can form more orderly crystals, potentially improving drug stability, solubility, and administration methods. While high launch costs and regulatory hurdles remain, companies are actively working to scale up missions in the coming years to test new cancer therapies.

Meanwhile, medical experts continue to emphasize the vital importance of early detection and routine screenings for other prevalent forms of the disease, such as colorectal cancer. Health organizations in the United States and Brazil highlight that colorectal cancer remains one of the most frequently diagnosed tumors, prompting medical guidelines to recommend lowering the age for routine screenings to 45 for individuals at average risk.

Physicians point out that early-stage colorectal cancer often develops without noticeable warning signs, making regular screenings like colonoscopies and fecal immunochemical tests critical for survival. Maintaining healthy lifestyle habits, including regular exercise, a fiber-rich diet, and avoiding tobacco and excessive alcohol, can also help reduce overall health risks.

As medical researchers explore orbital manufacturing to refine future treatments and healthcare providers urge proactive screenings on Earth, public figures like Biden continue to raise awareness about the realities of living with the disease. Biden has repeatedly encouraged men to prioritize early detection, emphasizing that proactive medical consultations drastically improve survival rates when conditions are caught early.